- $6.83bn
- $13.26bn
- $3.59bn
- 62
- 88
- 74
- 87
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 2,339 | 1,911 | 1,844 | 2,466 | 2,514 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 2,265 | 1,374 | 2,228 | 2,406 | 2,425 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 1,538 | 621 | 1,490 | 1,476 | 1,144 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,202 | 497 | 1,168 | 1,151 | 881 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,202 | 497 | 1,168 | 1,151 | 881 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,195 | 482 | 1,140 | 1,122 | 854 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.91 | 3.55 | 8.32 | 8.5 | 6.42 |
Dividends per Share |